Evidence map›Paper›PMID 26178786›Full record

ArticleGenes & development2015

Transcriptional repression by PRC1 in the absence of H2A monoubiquitylation.

Ana Raquel Pengelly, Reinhard Kalb, Katja Finkl, Jürg Müller

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 115 papers.

0numbers the graph read from it
0cells of the map it votes in
115citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

115 citing papers in PubMed, 206 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Research square · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Polycomb protein RYBP facilitates super-enhancer activity.Molecular medicine (Cambridge, Mass.) · 2024
    Article
  15. Article
  16. Review
  17. Article
  18. Genes & development · 2024
    Article
  19. Review
  20. Article

55 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ana Raquel PengellyLaboratory of Chromatin Biology, Max Planck Institute of Biochemistry, 82152 Martinsried, Germany.
Reinhard KalbLaboratory of Chromatin Biology, Max Planck Institute of Biochemistry, 82152 Martinsried, Germany.
Katja FinklLaboratory of Chromatin Biology, Max Planck Institute of Biochemistry, 82152 Martinsried, Germany.
Jürg MüllerLaboratory of Chromatin Biology, Max Planck Institute of Biochemistry, 82152 Martinsried, Germany.
Max Planck Institute of Biochemistry · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Histone H2A monoubiquitylation (H2Aub) is considered to be a key effector in transcriptional repression by Polycomb-repressive complex 1 (PRC1). We analyzed Drosophila with a point mutation in the PRC1 subunit Sce that abolishes its H2A ubiquitylase activity or with point mutations in the H2A and H2Av residues ubiquitylated by PRC1. H2Aub is essential for viability and required for efficient histone H3 Lys27 trimethylation by PRC2 early in embryogenesis. However, H2Aub-deficient animals fully maintain repression of PRC1 target genes and do not show phenotypes characteristic of Polycomb group mutants. PRC1 thus represses canonical target genes independently of H2Aub.

Indexed as

Drosophila ProteinsGene Expression Regulation, DevelopmentalAnimalsDrosophilaHistonesMetamorphosis, BiologicalMutationPolycomb Repressive Complex 1UbiquitinationUbiquitin-Protein LigasesDrosophila ProteinsHistonesPolycomb Repressive Complex 1Ubiquitin-Protein LigasesDrosophilaH2A and H2Av monoubiquitylationPolycombPRC1transcriptional repression

Identifiers

PMID26178786
PMCPMC4526733
OpenAlexW2134244982

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.